News-Medical.Net on MSN1d
Solascure enrols first patient in a next phase II clinical trial to advance Aurase Wound GelSOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback